Cargando…

FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer

INTRODUCTION: Our previous clinical study demonstrated that the under-expression of FOXF2 is associated with early-onset metastasis and poor prognosis of patients with triple-negative breast cancer. In this study, we further characterized the role of FOXF2 in metastasis of basal-like breast cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qing-Shan, Kong, Peng-Zhou, Li, Xiao-Qing, Yang, Fan, Feng, Yu-Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361145/ https://www.ncbi.nlm.nih.gov/pubmed/25848863 http://dx.doi.org/10.1186/s13058-015-0531-1

Ejemplares similares

FOXF2 oppositely regulates stemness in luminal and basal-like breast cancer cells through the Wnt/beta-catenin pathway
por: Zhang, Xiao, et al.
Publicado: (2022)

FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1()()
por: Wang, Shuyang, et al.
Publicado: (2018)

FOXF2 reprograms breast cancer cells into bone metastasis seeds
por: Wang, Shuo, et al.
Publicado: (2019)

The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
por: Fedele, Monica, et al.
Publicado: (2017)

Decreased FOXF2 mRNA Expression Indicates Early-Onset Metastasis and Poor Prognosis for Breast Cancer Patients with Histological Grade II Tumor
por: Kong, Peng-Zhou, et al.
Publicado: (2013)

Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells
por: Miao, Liyun, et al.
Publicado: (2016)

ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer
por: Liu, Dian, et al.
Publicado: (2020)

ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
por: Thomas, Christoforos, et al.
Publicado: (2012)

LRIG1 opposes epithelial to mesenchymal transition and inhibits invasion of basal-like breast cancer cells
por: Yokdang, Nucharee, et al.
Publicado: (2015)

MicroRNA-182 promotes proliferation and metastasis by targeting FOXF2 in triple-negative breast cancer
por: Zhang, Xingzeng, et al.
Publicado: (2017)

Small breast epithelial mucin promotes the invasion and metastasis of breast cancer cells via promoting epithelial-to-mesenchymal transition
por: Li, Qiu-Hua, et al.
Publicado: (2020)

Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011)

Glutamine deficiency promotes recurrence and metastasis in colorectal cancer through enhancing epithelial–mesenchymal transition
por: Sun, Hongyan, et al.
Publicado: (2022)

SOX5 promotes cell invasion and metastasis via activation of Twist-mediated epithelial–mesenchymal transition in gastric cancer
por: You, Jianxiong, et al.
Publicado: (2019)

Folate deficient tumor microenvironment promotes epithelial-to-mesenchymal transition and cancer stem-like phenotypes
por: Su, Yen-Hao, et al.
Publicado: (2016)

Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)

PTIP promotes recurrence and metastasis of hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Leng, Shusheng, et al.
Publicado: (2017)

MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
por: Yang, Fan, et al.
Publicado: (2014)

Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration
por: Meyer-Schaller, Nathalie, et al.
Publicado: (2018)

Goosecoid Promotes the Metastasis of Hepatocellular Carcinoma by Modulating the Epithelial-Mesenchymal Transition
por: Xue, Tong-Chun, et al.
Publicado: (2014)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

HOXD9 promote epithelial‐mesenchymal transition and metastasis in colorectal carcinoma
por: Liu, Mengwei, et al.
Publicado: (2020)

CPEB1 Mediates Epithelial-to-Mesenchyme Transition and Breast Cancer Metastasis
por: Nagaoka, Kentaro, et al.
Publicado: (2015)

High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition
por: Zeng, Ling-Hui, et al.
Publicado: (2019)

Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis
por: Walia, Vijay, et al.
Publicado: (2011)

Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer
por: He, Wei-Peng, et al.
Publicado: (2022)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
por: Demirkan, Binnaz
Publicado: (2013)

NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription()()
por: Zhang, Jian, et al.
Publicado: (2019)

Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma
por: Hao, Chong, et al.
Publicado: (2014)

Sciellin mediates mesenchymal-to-epithelial transition in colorectal cancer hepatic metastasis
por: Chou, Chuan-Kai, et al.
Publicado: (2016)

Translationally Controlled Tumor Protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis
por: Bae, Seong-Yeon, et al.
Publicado: (2015)

Lung cancer-associated mesenchymal stem cells promote tumor metastasis and tumorigenesis by induction of epithelial–mesenchymal transition and stem-like reprogram
por: Yan, Cihui, et al.
Publicado: (2021)

WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition
por: Zhou, Yun, et al.
Publicado: (2016)

Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition
por: Dong, Zhizhen, et al.
Publicado: (2018)

PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition
por: Weng, Xingyue, et al.
Publicado: (2019)

Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Du, Qiang, et al.
Publicado: (2023)

Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
por: Masuda, Tomonori, et al.
Publicado: (2023)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
por: Fu, Zheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1satlbrrsls3fmm4raf2aqqnj8